We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Elan and Transition Therapeutics Receive Key Patent for Alzheimer’s Disease Treatment with ELND005

News   Apr 24, 2009

 
Elan and Transition Therapeutics Receive Key Patent for Alzheimer’s Disease Treatment with ELND005
 
 
 

RELATED ARTICLES

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

Novel Strategy for Synthesizing Complex Natural Products

News

Scientists have succeeded in synthesizing two complex products from a group which could be used in the development of new drugs.

READ MORE

A Way To Extend Survival Rates for Heart Failure?

News

For the first time in preclinical studies, researchers have shown that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay progression of congestive heart failure and extend survival rates.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE